These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat. Berecek KH, Nagahama S, Oparil S. J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756 [Abstract] [Full Text] [Related]
6. [Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol]. Reyes Toso CF, Linares LM, Rodríguez RR. Medicina (B Aires); 1992 Dec; 52(3):240-4. PubMed ID: 1342690 [Abstract] [Full Text] [Related]
8. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril). Baum T, Watkins RW, Sybertz EJ, Ahn HS, Nelson S, Coleman W, Tedesco R, Pula KK, Rivelli M, Sabin C. Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941 [Abstract] [Full Text] [Related]
9. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition. Guidi E, Hollenberg NK. J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668 [Abstract] [Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S. Int J Clin Pharmacol Res; 1985 Dec; 5(6):429-38. PubMed ID: 3005182 [Abstract] [Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK, Dubinion JH, Mi Z. Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [Abstract] [Full Text] [Related]
14. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy. Gröne HJ, Helmchen U. Lab Invest; 1986 Jun; 54(6):645-55. PubMed ID: 3012198 [Abstract] [Full Text] [Related]
15. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A. Ann Acad Med Stetin; 1999 Jun; Suppl 52():1-93. PubMed ID: 10589103 [Abstract] [Full Text] [Related]
16. Blood pressure responses to enalapril in rats with one- and two-kidney DOC-NaCl hypertension. Arvola P, Nurmi AK, Säynävälammi P, Manninen V, Vapaatalo H. Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):67-71. PubMed ID: 2540388 [Abstract] [Full Text] [Related]
17. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Arendshorst WJ, Chatziantoniou C, Daniels FH. Kidney Int Suppl; 1990 Nov; 30():S92-6. PubMed ID: 2259085 [Abstract] [Full Text] [Related]
18. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake. Olsen ME, Meydrech EF. J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230 [Abstract] [Full Text] [Related]
19. Angiotensin II blockade and the functions of the renin-angiotensin system. Davis JO, Freeman RH, Watkins BE, Stephens GA, Williams GM. Prog Biochem Pharmacol; 1976 Oct; 12():1-15. PubMed ID: 798202 [Abstract] [Full Text] [Related]
20. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M, Schiavi P, Vincent M, Schmitt H. J Cardiovasc Pharmacol; 1984 Oct; 6(6):1076-82. PubMed ID: 6084763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]